Early Modulation of Circulating MicroRNAs Levels in HER2-Positive Breast Cancer Patients Treated with Trastuzumab-Based Neoadjuvant Therapy

Circulating microRNA (ct-miRNAs) are able to identify patients with differential response to HER2-targeted therapy. However, their dynamics are largely unknown. We assessed 752 miRNAs from 52 NeoALTTO patients with plasma pairs prior and two weeks after trastuzumab. Increased levels of ct-miR-148a-3...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Cosimo, Serena, Appierto, Valentina, Pizzamiglio, Sara, Silvestri, Marco, Baselga, José, Piccart, Martine, Huober, Jens, Izquierdo, Miguel, de la Pena, Lorena, Hilbers, Florentine S., de Azambuja, Evandro, Untch, Michael, Pusztai, Lajos, Pritchard, Kathleen, Nuciforo, Paolo, Vincent-Salomon, Anne, Symmans, Fraser, Apolone, Giovanni, de Braud, Filippo G., Iorio, Marilena V., Verderio, Paolo, Daidone, Maria Grazia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073028/
https://www.ncbi.nlm.nih.gov/pubmed/32085669
http://dx.doi.org/10.3390/ijms21041386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073028/
https://www.ncbi.nlm.nih.gov/pubmed/32085669
http://dx.doi.org/10.3390/ijms21041386

Ejemplares similares